Ignite Creation Date:
2025-12-24 @ 5:36 PM
Ignite Modification Date:
2026-01-02 @ 9:03 AM
Study NCT ID:
NCT01147068
Status:
COMPLETED
Last Update Posted:
2012-11-26
First Post:
2010-06-16
Is Gene Therapy:
True
Has Adverse Events:
True
Brief Title:
Safety and Immunogenicity of PanBlok Influenza Vaccine in Healthy Adults
Sponsor:
Protein Sciences Corporation
Organization:
Organization Data
Organization:
Class:
INDUSTRY
Study ID:
PSC22 GLA-SE
Study Type:
None
Study Domain:
None
Study Link:
None
Lead Sponsor:
Lead Sponsor Class:
INDUSTRY
Responsible Party:
Responsible Party Title:
Responsible Party Type:
PRINCIPAL_INVESTIGATOR
Responsible Party Affiliation:
Old Name:
None
Old Organization:
None